MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
3.770
-0.020 (-0.53%)
Jan 26, 2026, 2:14 PM EST - Market open
MDxHealth Revenue
MDxHealth had revenue of $27.43M in the quarter ending September 30, 2025, with 17.65% growth. This brings the company's revenue in the last twelve months to $103.07M, up 21.68% year-over-year. In the year 2024, MDxHealth had annual revenue of $90.05M with 28.29% growth.
Revenue (ttm)
$103.07M
Revenue Growth
+21.68%
P/S Ratio
1.81
Revenue / Employee
$330,349
Employees
312
Market Cap
186.60M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 90.05M | 19.86M | 28.29% |
| Dec 31, 2023 | 70.19M | 33.14M | 89.43% |
| Dec 31, 2022 | 37.05M | 14.82M | 66.62% |
| Dec 31, 2021 | 22.24M | 3.78M | 20.47% |
| Dec 31, 2020 | 18.46M | 6.68M | 56.64% |
| Dec 31, 2019 | 11.79M | -16.61M | -58.50% |
| Dec 31, 2018 | 28.40M | -12.11M | -29.90% |
| Dec 31, 2017 | 40.51M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Myriad Genetics | 825.30M |
| OPKO Health | 642.07M |
| Fulgent Genetics | 315.55M |
| FONAR | 105.43M |
| Biodesix | 80.17M |
| Prenetics Global | 77.08M |
| Burning Rock Biotech | 75.75M |
| Personalis | 69.10M |
MDXH News
- 14 days ago - MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences - GlobeNewsWire
- 20 days ago - Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer - GlobeNewsWire
- 2 months ago - MDxHealth SA (MDXH) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Angle PLC Announces Strategy Update - Accesswire
- 6 months ago - Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne - GlobeNewsWire
- 7 months ago - Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change - GlobeNewsWire
- 9 months ago - MDxHealth SA (MDXH) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 9 months ago - MDxHealth Reports Q1-2025 Results - GlobeNewsWire